# US 2023/0057488 A1 · Method and apparatus for pulmonary interventions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0057488 A1
- Document ID: US20230057488A1
- Status: Published application
- Kind: A1
- Application number: 17/954,549
- Filed: 2022-09-28
- Published: 2023-02-23
- Earliest claimed: 2020-03-31
- Assignees: AerWave Medical, Inc.
- Applicants: AerWave Medical, Inc.
- Inventors: Reinhard J. Warnking; Satoshi Nishiaoki
- Web page: https://patentgrep.com/patent/US20230057488A1

## CPC

- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61B 8/085: {for locating body or organic structures, e.g. tumours, calculi, blood vessels, nodules}
- A61B 8/12: in body cavities or body tracts, e.g. by using catheters
- A61B 8/429: {characterised by determining or monitoring the contact between the transducer and the tissue}
- A61B 8/445: {Details of catheter construction}
- A61N 7/022: {intracavitary}
- A61B 1/00082: {Balloons}
- A61B 34/73: {Manipulators for magnetic surgery}
- A61B 2018/00541: {Lung or bronchi}
- A61N 2007/0004: {Applications of ultrasound therapy}
- A61N 2007/003: {Destruction of nerve tissue}
- A61N 2007/0043: {intra-cavitary}
- A61N 2007/0052: {using the same transducer for therapy and imaging}
- A61N 2007/0082: {Scanning transducers}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer (11) is inserted into the bronchus as, for example, by advancing the distal end of a catheter (10) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume (13) as, for example, at least about 1 cm3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

Apparatus for treating pulmonary conditions in a mammalian subject, comprising:
an ultrasound transducer adapted for insertion into and activation in a bronchial section of the mammalian subject and for emitting ultrasound energy in the bronchial section adapted to inactivate conduction of bronchial nerves alongside the bronchial section; and
an actuator or control unit electrically connected to the ultrasound transducer, the actuator or control unit being configured to control the ultrasound transducer to transmit ultrasound energy into an impact volume at least partially surrounding the bronchial section, the ultrasound energy being in an amount effective to inactivate conduction of bronchial nerves throughout the impact volume,
wherein the actuator or control unit is configured to control the ultrasound transducer to:
energize the ultrasound transducer to emit a pulse at a sub-therapeutic level while the ultrasound transducer is disposed proximate to a treatment site in the bronchial section;
receive, via the ultrasound transducer, ultrasound echoes from organic tissues of the mammalian subject in response to the pulse;
process and analyze a volume-integrated A-mode signal from the ultrasound transducer, representing an accumulated intensity of the ultrasound echoes,
measure a time delay of the volume integrated A-mode signal and therewith determine size of the bronchial section; and
control the ultrasound transducer to vary the amount of the therapeutically effective ultrasound energy in accordance with the determined size of the bronchial section taking into account efficiency variations.

### Claim 20 (depends on 19)

The apparatus of claim 19, wherein the actuator or control unit is configured to control the ultrasound transducer to transmit ultrasound energy at an acoustic power level of approximately 10 to approximately 20 watts for approximately 10 to approximately 20 seconds to provide a dose of approximately 100 to approximately 400 joules in the impact volume.

### Claim 21 (depends on 19)

The apparatus of claim 19 wherein the actuator or control unit is configured to control the ultrasound transducer to transmit ultrasound energy in a pulsed mode to cause mechanical stress on nerve fibers through cavitational effects.

### Claim 22 (depends on 19)

The apparatus of claim 19, wherein the actuator or control unit is configured to control the transducer and cooling fluid circulation so as to maintain temperature of a section of bronchial wall of the bronchial section below 65° C. while achieving a temperature above 42° C. throughout the impact volume.

### Claim at position 6

23-30. (canceled)

### Claim 31 (depends on 19)

The apparatus of claim 19, wherein the actuator or control unit is further configured to control the ultrasound transducer to:
process and analyze a volume-integrated A-mode signal from the ultrasound transducer, representing an accumulated intensity of the ultrasound echoes, to determine presence of cartilage along the bronchial section; and
activate the ultrasound transducer to transmit ultrasound therapeutic waveform energy through a wall of the bronchial section at one or more locations along the bronchial section determined by the analyzing of the volume integrated A-mode signal to be without cartilage.

### Claim 32 (depends on 31)

The apparatus of claim 31, wherein the actuator or control unit is further configured to analyze the volume integrated A-mode signal to distinguish a relative minimum of the volume integrated A-mode signal with respect to degree of insertion of the ultrasound transducer in the bronchial section, thereby enabling transmission of therapeutically effective focused ultrasound energy from the ultrasound transducer through the wall of the bronchial section at the one or more locations along the bronchial section without cartilage and into the impact volume.

### Claim 33 (depends on 31)

The apparatus of claim 31 wherein the ultrasound transducer is disposed inside a balloon configured to receive cooling fluid during the activating of the ultrasound transducer, wherein the actuator or control unit is further configured to measure cooling fluid volume and pressure and to determine a point of rapid pressure increase without significant volume increase which corresponds with a lumen size of the bronchial section at a treatment site and to adjust ultrasound energy accordingly.

### Claim 34 (depends on 19)

The apparatus of claim 19 wherein the bronchial section is a secondary bronchial section, the ultrasound transducer being adapted for insertion into and activation in secondary bronchial sections of the mammalian subject instead of in main bronchi of the mammalian subject and for emitting, in secondary bronchial sections, ultrasound energy adapted to inactivate conduction of bronchial nerves alongside the secondary bronchial sections, the actuator or control unit being configured to control the ultrasound transducer to transmit ultrasound energy into an impact volume at least partially surrounding any one of the secondary bronchial sections, the ultrasound energy being in an amount effective to inactivate conduction of bronchial nerves throughout the impact volume.

### Claim 35

Apparatus for treating bronchial conditions in a mammalian subject, comprising:
an ultrasound transducer adapted for insertion into and activation in a bronchus of the mammalian subject and for emitting ultrasound energy in the bronchus adapted to inactivate conduction of bronchial nerves alongside the bronchus; and
an actuator or control unit electrically connected to the ultrasound transducer, the actuator or control unit being configured to control the ultrasound transducer to transmit ultrasound energy into an impact volume at least partially surrounding the bronchus, the ultrasound energy being in an amount effective to inactivate conduction of bronchial nerves throughout the impact volume,
wherein the actuator or control unit is configured to control the ultrasound transducer to:
energize the ultrasound transducer to emit a pulse at a sub-therapeutic level while the ultrasound transducer is disposed proximate to a treatment site in the bronchus;
receive, via the ultrasound transducer, ultrasound echoes from organic tissues of the mammalian subject in response to the pulse;
process and analyze a volume-integrated A-mode signal from the ultrasound transducer, representing an accumulated intensity of the ultrasound echoes, to determine one or more locations along the bronchus for treatment; and
activate the ultrasound transducer to transmit ultrasound therapeutic waveform energy through a wall of the bronchus at the one or more locations along the bronchus,
wherein the ultrasound transducer is disposed inside a balloon configured to receive cooling fluid during the activating of the ultrasound transducer, wherein the actuator or control unit is further configured to measure cooling fluid volume and pressure and to determine a point of rapid pressure increase without significant volume increase which corresponds with a lumen size of the bronchus at a treatment site and to adjust ultrasound energy accordingly.

### Claim 36 (depends on 35)

The apparatus of claim 35, wherein the actuator or control unit is further configured to analyze the volume integrated A-mode signal to distinguish a relative minimum of the volume integrated A-mode signal with respect to degree of insertion of the ultrasound transducer in the bronchus.

### Claim 37 (depends on 35)

The apparatus of claim 35, wherein the actuator or control unit is further configured to:
measure a time delay of the volume integrated A-mode signal and therewith determine size of the bronchus; and
control the ultrasound transducer to vary the amount of the therapeutically effective ultrasound energy in accordance with the determined size of the bronchus taking into account efficiency variations.
